Neglected diseases in cardiology: A call for urgent action

Nature Clinical Practice Cardiovascular Medicine

Volumn 5, Issue 4, 2008, Pages 176-177

  Yacoub, Sophie ^a   Kotit, Susy ^b   Mocumbi, Ana Olga ^c   Yacoub, Magdi H ^d  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b Maputo Heart Institute   (South Africa)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIPARASITIC AGENT; ANTIRETROVIRUS AGENT; BENZNIDAZOLE; CARDIOVASCULAR AGENT; NIFURTIMOX; PENICILLIN G;

ARTIFICIAL HEART PACEMAKER; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CHAGAS DISEASE; CHRONIC DISEASE; CLINICAL EFFECTIVENESS; CONGESTIVE CARDIOMYOPATHY; DEFIBRILLATOR; DISEASE ASSOCIATION; EARLY DIAGNOSIS; ELECTROCARDIOGRAPHY; HEALTH CARE ACCESS; HEART FAILURE; HEART MUSCLE FIBROSIS; HEART SURGERY; HEART TRANSPLANTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; LOWEST INCOME GROUP; MORBIDITY; MORTALITY; PARASITE TRANSMISSION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PUBLIC HEALTH; PULMONARY HYPERTENSION; REVIEW; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; SCHISTOSOMIASIS; STREPTOCOCCUS; TRYPANOSOMA CRUZI; TUBERCULOUS PERICARDITIS; UNSPECIFIED SIDE EFFECT; VALVULAR HEART DISEASE; VECTOR CONTROL;

CARDIOLOGY; CARDIOVASCULAR DISEASES; HUMANS; INFECTION; MORBIDITY; PRACTICE GUIDELINES AS TOPIC; SURVIVAL RATE; WORLD HEALTH;

EID: 41549140151     PISSN: 17434297     EISSN: 17434300     Source Type: Journal    
DOI: 10.1038/ncpcardio1129     Document Type: Review

References (11)

1. WHO (2003) The World Health Report 2003: Shaping the Future. Geneva: WHO
2. Yacoub MH (2007) Establishing pediatric cardiovascular services in the developing world: A wake-up call. Circulation 116: 1876-1878
3. Sliwa K et al. (2005) Epidemiology and etiology of cardiomyopathy in Africa. Circulation 112: 3577-3583
4. Marijon E et al. (2007) Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med 357: 470-476
5. Mocumbi AO et al.: Neglected tropical cardiomyopathies II: endomyocardial fibrosis. Heart, in press
6. Yacoub S et al. (2007) Neglected tropical cardiomyopathies I: Chagas disease. Heart 94: 244-248
7. Trouiller P et al. (2002) Drug development for neglected diseases: a deficient market and a public-health policy failure. Lancet 359: 2188-2194
8. de Andrade AL et al. (1996) Randomised trial of efficacy of benznidazole treatment of early Trypanosoma cruzi infection. Lancet 348: 1407-1413
9. WHO (online 3 July 2007) Now global effort to eliminate Chagas disease [http://www.who.int/mediacentre/news/releases/2007/pr36/en/index.html] (accessed 19 December 2007)
10. Australian Institute of Health and Welfare (2004) Rheumatic heart disease: All but forgotten in Australia except among Aboriginal and Torres Strait Islander peoples. Bulletin No. 16. Canberra: AIHW
11. Ntsekhe M and Hakim J (2005) Impact of human immunodeficiency virus infection on cardiovascular disease in Africa. Circulation 112 3602-3607